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Overview

Results

Research Question: Does the use of a cryo-balloon catheter during
the endocardial portion of a convergent procedure elicit greater
success rates towards eliminating recurrent atrial fibrillation than
using a radiofrequency catheter?

Methods

Procedural Complications
– A total of two patients (6.4%) experienced rare adverse
effects from the operation.
– One patient suffered from pericardial effusion and one
from a hemoperitoneum with bleeding around trocar sites.
– Both patients recovered successfully.
– There were no procedural mortalities, no atrioesophogeal
fistulas, and no pericardial tamponade.

Success of Convergent Procedure using cryo-balloon
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Arrhythmia-free Patients

Background:Traditional catheter based treatment for atrial
fibrillation (AF) uses radiofrequency as a source of energy for the
ablation of atrial tissue. This is an endocardial (inside the heart)
technique. The success rate of this technique at one year is around
50-60%1. In the last three years, a novel technology using a
combined/hybrid trans-diaphragmatic surgical epicardial (outside the
heart) ablation with endocardial (inside the heart) ablation
techniques have had one-year success rates close to 80%2. This is
called the Convergent Procedure (CP) 3. The CP can be done with
either radiofrequency ablation (RF), or with a cryo-balloon catheter
to create the endocardial lesion set.The cryo-balloon technique may
be a preferred approach, as it creates improved endocardial
coverage of the pulmonary veins. Limited data is available on the
cryo-balloon technique for CP.
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Study limitations
– A retrospective review of symptomatic AF patients that
received Convergent Procedure with a cryo-balloon
ablation
– No quality of life survey administered.
– No control group.
– Many patients underwent their CP less than a year before
the conduction of study. Thus, limited follow-up data was
available.

Conclusions
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From October 2013 to May 2015, 31 AF patients underwent the
convergent procedure with cryo-balloon endocardial ablation at
LVHN. Patients were managed postoperatively medically and
followed up with in the office 1 month, 3 months, 6 months, and
12 months after the surgery. Most (89%) patients received an
implantable monitoring device that was interrogated at each visit
for arrhythmias. Medical records were reviewed to determine preoperative comorbidities and post-operative outcomes.
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• AF patients are treated medically, through cardioversions, and/or with traditional
ablations.
• If all these treatment options continue to fail, patients are considered appropriate
candidates for the convergent procedure.

• A cardiothoracic surgeon enters the peritoneal cavity with a radiofrequency ablation
device through a small incision approx. 2 cm below the xiphoid process.
• The surgeon ablates the posterior aspect of the heart in a linear fashion from the left
pulmonary veins to the right pulmonary veins

• An electrophysiologist positions a cryo-balloon catheter in each of the four ostia of the
pulmonary veins, ensuring occlusion via ICE imaging and lack of color flow.
• The cryo-balloon is then inflated with a liquid refrigerant that evaporates and scars the
Endocardial
tissue of the pulmonary vein, thus eliminating any electrical conduction that could
Ablation
interfere with electrical currents in the atria and cause atrial fibrillation

Postoperative
Follow up

• After surgery, patients were started on amiodarone, steroids, anticoagulants, and antiinflammatories
• At the follow-up, patients’ monitoring devices were interrogated and ECGs were
administered to determine heart rhythm.
• Medication was adjusted as needed.
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This study of 31 patients suggests that the use of a cyro-balloon
catheter for endocardial ablation during the convergent procedure
is a viable method to eliminate the recurrence of persistent atrial
fibrillation and arrhythmias.

Population Demographics and Comorbidities
Post-operative Therapies in response to Further study is warranted that obtains a larger sample size of CP
Characteristic
Subjects
patients and allows more time post-operatively for follow-up data
N
31
Recurrent Arrhythmia
Age (years), mean (range)
66 (40-81)
collection. Other data should be collected on the time and cost
3%
Sex:Male, n (%)
23 (74.2)
efficiency of the cryo-balloon versus radiofrequency technique.
Paroxysmal AF, n (%)
9 (30)
10%
Re-ablation
Persistent AF, n (%)
22 (70)
Hypertension, n (%)
23 (74.2)
Obesity, n (%)
8 (25.8)
Congestive Heart Failure, n (%) 9 (29)
Post-operative
Current/Past Tobacco Use, n (%) 14 (48.3)
Cardioversion
Sleep Apnea, n (%)
11 (34.4)
Pacemaker, n (%)
7 (22.6)
Previous Ablation, n (%)
13 (38.7)
None
87%
REFERENCES
Previous Cardioversion, n (%)
17 (54.8)
1. JR Edgerton , et al. (2008). Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical
Family Hist. HD, n (%)
13 (43.3)
treatment of atrial fibrillation. The Annals of Thoracic Surgery, 86, Vol 1, 35-39.
2. M Zembala, et al. Minimally invasive hybrid ablation procedure for the treatment of persistent atrial fibrillation: one year
results. Kardiologia Polska 2012; 70, 8: 819–828
3. Gehi et al. (2013). Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial
fibrillation. The Heart Rhythm Society, 10, No 1, 22-28.

© 2014 Lehigh Valley Health Network

